Two types of COVID-19 tests, the rapid antigen test and the polymerase chain reaction (PCR) test, are available in the United States. The PCR typically relies on lab testing and is still considered ...

Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...

Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...

PCR processes are the diagnostic gold standard when it comes to identifying coronavirus infections. Unlike rapid antigen tests, they function even in the case of a low viral load and detect the ...

Patients in rural communities often lack timely access to innovative infectious disease testing because diagnostic laboratories are located far away. Long transport times and logistical barriers delay ...

In this webinar, our speakers will provide an introduction into the epidemiology of influenza A/B, RSV, COVID-19, Adenovirus, Human Metapneumovirus, Rhinovirus, Enterovirus, and Parainfluenza, ...

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...